Rami Apelian

Eptinezumab: the first approved infusion medication for migraine prevention 1:06
Eptinezumab: the first approved infusion medication for migraine prevention
Rami Apelian • 21 Jun 2022
Future directions in migraine prevention treatment 0:35
Future directions in migraine prevention treatment
Rami Apelian • 21 Jun 2022
Differences and similarities between PROMISE-1 & PROMISE-2 1:10
Differences and similarities between PROMISE-1 & PROMISE-2
Rami Apelian • 21 Jun 2022
Safety of eptinezumab in migraine patients 1:34
Safety of eptinezumab in migraine patients
Rami Apelian • 21 Jun 2022
PROMISE-1 & PROMISE-2: eptinezumab in episodic and chronic migraine 1:08
PROMISE-1 & PROMISE-2: eptinezumab in episodic and chronic migraine
Rami Apelian • 21 Jun 2022
The content of VJNeurology is intended for healthcare professionals